Evidence map›Paper›PMID 39870501›Full record

ArticleBMJ open2025

Efficacy and safety of an algorithm using C-reactive protein to guide antibiotic therapy applied through a digital clinical decision support system: a study protocol for a randomised controlled clinical trial.

Vitoria Moura Leite Rabelo Rezende, Isabela Nascimento Borges, Cecilia Gomez Ravetti, Renan Pedra De Souza, Paula Frizera Vassalo, Ana Clara de Paula Caldas, Felipe Rodrigues Gatto, Getulio Hideyoshi Okamura, Raquel Lopes de Brito Lacerda, Pedro R Povoa and 1 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05841875 (Efficacy and Safety of a Protocol Using C-reactive Protein to Guide Antibiotic Therapy Applied Through a Digital Clinical Decision Support Tool), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05841875 nacompletednot on this map

Efficacy and Safety of a Protocol Using C-reactive Protein to Guide Antibiotic Therapy Applied Through a Digital Clinical Decision Support Tool: a Randomized Clinical Trial

TypeinterventionalSponsorFederal University of Minas GeraisRan2023 to 2024Enrolled110ConditionsSystemic InfectionArmsC reactive protein algorithm
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vitoria Moura Leite Rabelo RezendeUniversidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil vitoriamlrrezende@gmail.com.ORCID http://orcid.org/0009-0006-8149-0778
Isabela Nascimento BorgesUniversidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Cecilia Gomez RavettiUniversidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.ORCID http://orcid.org/0000-0002-6349-3063
Renan Pedra De SouzaUniversidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Paula Frizera VassaloUniversidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Ana Clara de Paula CaldasUniversidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Felipe Rodrigues GattoUniversidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Getulio Hideyoshi OkamuraUniversidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Raquel Lopes de Brito LacerdaUniversidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Pedro R PovoaHospital de Sao Francisco Xavier, Lisboa, Portugal.
Vandack NobreUniversidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.ORCID http://orcid.org/0000-0002-7922-0422

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe escalating resistance of microorganisms to antimicrobials poses a significant public health threat. Strategies that use biomarkers to guide antimicrobial therapy-most notably Procalcitonin (PCT) and C-reactive protein (CRP)-show promise in safely reducing patient antibiotic exposure. While CRP is less studied, it offers advantages such as lower cost and broader availability compared with PCT. METHODS AND ANALYSIS: This randomised clinical trial aims to evaluate a novel algorithm for non-critically ill adult patients. The algorithm incorporates key clinical variables and CRP behaviour. It will be applied through a mobile application as a digital clinical decision support system. The primary goal will be to assess the algorithm's effectiveness in reducing treatment duration compared with standard care based on current guidelines, while ensuring patient safety by monitoring the occurrence of adverse events. ETHICS AND DISSEMINATION: Only patients who agree to participate in the study after reading the informed consent form will be included. This project was submitted for consideration to the Research Ethics Committee of the Federal University of Minas Gerais (COEP-UFMG) and received approval (Approval Number: 5.905.290). Collection of clinical and laboratory data from 200 patients is expected, extracted from electronic medical records and laboratory systems, along with serum samples stored for potential future analyses. Data will be preserved using the Research Electronic Data Capture platform, and serum samples will be stored in a regulated biorepository at UFMG. Access will be controlled via credentials, with privacy protections and anonymisation prior to sharing, which will occur during scientific publications. TRIAL REGISTRATION NUMBER: This trial was registered on ClinicalTrials.gov (NCT05841875) and was last updated on 5 December 2024 at 12:49.

Indexed as

AlgorithmsAnti-Bacterial AgentsC-Reactive ProteinDecision Support Systems, ClinicalAdultBiomarkersHumansMobile ApplicationsProcalcitoninRandomized Controlled Trials as TopicAnti-Bacterial AgentsBiomarkersC-Reactive ProteinProcalcitoninAnti-Bacterial AgentsAntibioticsClinical Decision-MakingeHealthGENERAL MEDICINE (see Internal Medicine)Telemedicine

Identifiers

PMID39870501
PMCPMC11772927

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.